View in EDS HTML Full Text PDF Full Text

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry.

Saved in:
Bibliographic Details
Title: The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry.
Authors: Diamantopoulos, Panagiotis1 (AUTHOR) pandiamantopoulos@gmail.com, Koumbi, Dafni2 (AUTHOR), Kotsianidis, Ioannis3 (AUTHOR), Pappa, Vasiliki4 (AUTHOR), Symeonidis, Argiris5 (AUTHOR), Galanopoulos, Athanasios6 (AUTHOR), Zikos, Panagiotis7 (AUTHOR), Papadaki, Helen A.8 (AUTHOR), Panayiotidis, Panayiotis9 (AUTHOR), Dimou, Maria9 (AUTHOR), Hatzimichael, Eleftheria10 (AUTHOR), Vassilopoulos, George11 (AUTHOR), Delimpasis, Susan12 (AUTHOR), Mparmparousi, Despoina13 (AUTHOR), Papageorgiou, Sotirios4 (AUTHOR), Variami, Eleni1 (AUTHOR), Kyrtsonis, Marie‐Christine9 (AUTHOR), Megalakaki, Aekaterini14 (AUTHOR), Kotsopoulou, Maria14 (AUTHOR), Repousis, Panagiotis14 (AUTHOR)
Source: Cancer Medicine. May2019, Vol. 8 Issue 5, p2056-2063. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.2090